PRIS may be diagnosed before ICU period for patients undergoing cardiopulmonary bypass.
There are many published articles on the clinical manifestations of propofol-related infusion syndrome (PRIS), but they are not the same in each case.(1)Moreover, PRIS is only encountered infrequently and, therefore, it may create a diagnostic challenge. Nearly all of the published articles on PRIS are related to the use of long-term (> 48 hour) propofol infusion with a dose range of at least 4-5 mg/kg/h. In this case, not only a short duration, but also a low-dose propofol administration seems to induce PRIS. A 73-year-old male patient under cardiopulmonary bypass (CPB) suffered from some clinical symptoms of PRIS, such as hyperlactatemia and persistent low metabolic acidosis which promptly resolved on the discontinuation of propofol. Therefore, we suggest that any propofol administration (bolus or infusion) may result in such clinical symptoms, which may be the earliest indicators of PRIS. When those symptoms are observed on propofol administration during cardiopulmonary bypass (CPB), the perfusionist must alert both the anaesthesiologist and the surgeon to stop the propofol in order to prevent the patient from further adverse effects of PRIS.
Near East University Hospital, Perfusion Services, Nicosia, Northern Cyprus, Turkey turkersahin@lycos.com.
Türker
T
Şahin
D000368:Aged; D002315:Cardiopulmonary Bypass; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D015742:Propofol / Q000008:administration & dosage / Q000009:adverse effects*; D000072736:Propofol Infusion Syndrome / Q000175:diagnosis* / Q000628:therapy*
D015742:Propofol
CPB; PRIS; propofol